<<>>>
TitleUrlVersionPublisher
Clomipraminehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.12.133620170504NCQA PHEMUR
Adverse Reaction to Therapy or Treatmenthttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.77720210916HL7 Patient Care WG Steward
Doxylaminehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.152220230217NCQA PHEMUR
BMI percentilehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.121.11.102820170504NCQA PHEMUR
Social Role or Activitieshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.106120210924HL7 Patient Care WG Steward
Hodgkins Diseasehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.24320150919CancerLinQ Steward
Statins Allergy Intolerancehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.64720230913Optum Steward
Hemoglobin A1C in diabetes mellitus poorly controlledhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.4220170622LUGPA Steward
Lost to Follow uphttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1047.23720161227Oncology Nursing Society Steward
COVID19 LOINC Value Set for SARS Coronavirus 2 (Next Generation Sequencing) Qualitative Results, All Sourceshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.507520220715Clinical Architecture
Neonatal Severe Neurological Complicationshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.15420210611Joint Commission
ObservationNonAllergyIntoleranceTypehttp://terminology.hl7.org/ValueSet/v3-ObservationNonAllergyIntoleranceType2.0.0
Support Network or Social Networkhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.123420210928HL7 Patient Care WG Steward
Pharmacological interventions for depressionhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.49220240511CancerLinQ Steward
Elective Inpatient Encounterhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1029.21220190314Joint Commission
ECOG Performance Status Resultshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.7643.2.101020190108Oncology Nursing Society Steward
Prenatal Care Bundle CPThttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1166.20420211119OPA Steward
Acanthamoeba Disease [Excluding Keratitis] (Tests for Acanthamoeba species by Culture and Identification Method)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1146.126220210121CSTE Steward
Aspirin / Carisoprodol / Codeinehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.196.11.130620170504NCQA PHEMUR
Intact Parathyroid Hormonehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.12920240613HL7 Patient Care WG Steward
Glycemic Screening Testshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1160.520230107American Medical Association Steward
Transverse Myelitis, SNOMED codes for AE reportinghttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1234.3920211123BEST System Steward
conditions_COPD SCThttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.16020230322Optum Steward
Delivery of Singletonhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1045.17320210611TJC EH Steward
Balance Assessmentshttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.83520210918HL7 Patient Care WG Steward
External Vagus Nerve Stimulation (SNOMEDCT)http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1034.55420210116American Academy of Neurology Steward
Hospital Measures-Immunodeficiency syndromehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.79620121025Lantana
Restless Leg Syndromehttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1222.75720210916HL7 Patient Care WG Steward
Ticagrelor Therapyhttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.3920210220TJC EH Steward
Hospital Measures-Lymphomahttp://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.97920121025Lantana
<<>>>731732733734735<<>>>